ScholarX

Browsing by Su, Wu-ChouAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 7 of 7

SCIESCOPUS
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations Results From the Phase II TROPION-Lung05 Study

Sands, Jacob; Ahn, Myung-Ju; Lisberg, Aaron; Cho, Byoung Chul; Blumenschein, George; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi; Yoh, Kiyotaka; Heist, Rebecca, et al.

ArticleIssue Date2025CitationJournal of Clinical Oncology, v.43, no.10PublisherLippincott Williams and Wilkins
SCIESCOPUS
Efficacy and safety of erdafitinib in patients with advanced or metastatic cholangiocarcinoma and <i>FGFR</i> alterations: Pooled analysis of RAGNAR and LUC2001 studies.

Pant, Shubham; Park, Joon Oh; Su, Wu-Chou; Schuler, Martin H.; Loriot, Yohann; Iyer, Gopa; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Prenen, Hans, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trialopen access

Park, Joon Oh; Feng, Yin-Hsun; Su, Wu-Chou; Oh, Do-Youn; Keam, Bhumsuk; Shen, Lin; Kim, Sang-We; Liu, Xiufeng; Liao, Huimin; Qing, Min, et al.

ArticleIssue Date2024CitationBMC CANCER, v.24, no.1PublisherBMC
SCIESCOPUS
Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05

Lisberg, Aaron; Ahn, Myung-Ju; Kitazono, Satoru; Cho, Byoung Chul; Blumenschein, George R.; Shum, Elaine; Pons-Tostivint, Elvire; Goto, Yasushi; Yoh, Kiyotaka; Paz-Ares, Luis G., et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Osimertinib plus Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTONopen access

Hartmaier, Ryan J.; Markovets, Aleksandra A.; Ahn, Myung Ju; Sequist, Lecia, V; Han, Ji-Youn; Cho, Byoung Chul; Yu, Helena A.; Kim, Sang-We; Yang, James Chih-Hsin; Lee, Jong-Seok, et al.

ArticleIssue Date2023CitationCANCER DISCOVERY, v.13, no.1, pp 98 - 113PublisherAMER ASSOC CANCER RESEARCH
SCIESCOPUS
Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNAopen access

Cheng, Jordan; Morselli, Marco; Huang, Wei-Lun; Heo, You Jeong; Pinheiro-Ferreira, Thalyta; Li, Feng; Wei, Fang; Chia, David; Kim, Yong; He, Hua-Jun, et al.

ArticleIssue Date2022CitationISCIENCE, v.25, no.7PublisherCELL PRESS
SCIESCOPUS
TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

Atmaca, Akin; Paz-Ares, Luis; Ahn, Myung-Ju; Lisberg, Aaron; Kitazono, Satoru; Cho, Byoung Chul; Blumenschein, George, Jr.; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi, et al.

ArticleIssue Date2024CitationONCOLOGY RESEARCH AND TREATMENT, v.47, pp 127 - 127PublisherKARGER
1
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어